References
- Blakley BW, Gupta AK, Myers SF, Schwan S. Risk factors for ototoxicity due to cisplatin. Arch Otolaryngol Head Neck Surg 1994; 120: 541–6
- Appenroth D, Winnefeld K. Role of glutathione for cisplatin nephrotoxicity in young and adult rats. Ren Fail 1993; 15: 135–9
- Clerici WJ, Hensley K, Dimartino DJ, Butterfield DA. Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants. Hear Res 1996; 98: 116–24
- Pierson MG, Moller AR. Prophylaxis of kanamycin-induced ototoxicity by a radioprotectant. Hear Res 1981; 4: 79–87
- Evans P, Halliwell B. Free radicals and hearing. Cause, consequence, and criteria. Ann N Y Acad Sci 1999; 884: 19–40
- Feghali JG, Liu W, Van De Water TR. L-n-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 2001; 111: 1147–55
- Li G, Frenz DA, Brahmblatt S, Feghali JG, Ruben RJ, Berggren D, et al. Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. Neurotoxicology 2001; 22: 163–76
- Teranishi MA, Nakashima T. Effects of trolox, locally applied on round windows, on cisplatin-induced ototoxicity in guinea pigs. Int J Pediatr Otorhinolaryngol 2003; 67: 133–9
- Chae HZ, Robison K, Poole L, Church G, Storz G, Rhee S. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc Natl Acad Sci U S A 1994; 91: 7017–21
- Rhee SG, Kang SW, Chang TS, Jeong W, Kim K. Peroxiredoxin, novel family of peroxidases. IUBMB Life 2001; 52: 35–41
- Rivolta MN, Holley MC. Cell lines in inner ear research. J Neurobiol 2002; 53: 306–18
- Kalinec F, Kalinec G, Boukhvalova M, Kachar B. Establishment and characterization of conditionally immortalized organ of corti cell lines. Cell Biol Int 1999; 23: 175–84
- Hoffman DW, Whitworth CA, Jones-King KL, Rybak LP. Potentiation of ototoxicity by glutathione depletion. Ann Otol Rhinol Laryngol 1988; 97: 36–41
- Garetz SL, Altschuler RA, Schacht J. Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo. Hear Res 1994; 77: 81–7
- Zachary AW, Ewald S, Robins Harris J, Leslie BP. Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 2003; 28: 32–40
- Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Rad Biol Med 2005; 38: 1543–52
- Watnabe K, Inai S, Jinnouchi K, Baba S, Yagi T. Expression of caspase-activated deoxyribonuclease (CAD) and caspase-3 (CPP32) in the cochlea of cisplatin (CDDP)-treated guinea pigs. Auris Nasis Larynx 2003; 30: 219–25
- Wang J, Ladrech S, Pujol R, Brabet P, Van De Water TR, Pujol JL. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment prevents cisplatin-induced hearing loss. Cancer Res 2004; 64: 9217–24
- Mukhopadhyay SS, Leung KS, Hicks MJ, Hastings PJ, Youssoufian H, Plon SE. Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J Cell Biol 2006; 175: 225–35
- Chang TS, Cho CS, Park S, Kang SW, Rhee SG. Peroxiredoxin III, a mitochondrion-specific peroxidase, regulates apoptotic signaling by mitochondria. J Biol Chem 2004; 279: 41975–84